Catalyst Pharmaceuticals, Inc.CPRXNASDAQ
Loading
Cash Flow Under PressureContracting
Percentile Rank93
3Y CAGR+21.6%
5Y CAGR+35.9%
Year-over-Year Change
Cash generated from core business operations
3Y CAGR
+21.6%/yr
Annual compound
5Y CAGR
+35.9%/yr
Recent deceleration
Percentile
P93
Near historical high
vs 5Y Ago
4.6x
Strong expansion
Streak
1 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $208.67M | -13.0% |
| 2024 | $239.81M | +67.0% |
| 2023 | $143.60M | +23.7% |
| 2022 | $116.05M | +92.2% |
| 2021 | $60.37M | +34.1% |
| 2020 | $45.03M | +30.1% |
| 2019 | $34.61M | +234.7% |
| 2018 | $-25.70M | -87.0% |
| 2017 | $-13.74M | +23.5% |
| 2016 | $-17.96M | - |